title: Olanzapine-induced QTc prolongation in a patient with Wolff-Parkinson-White syndrome.
authors.forename: Kuan-Pin
authors.initials: KP
authors.lastname: Su
authors.forename: Hsien-Yuan
authors.initials: HY
authors.lastname: Lane
authors.forename: Chiao-Lin
authors.initials: CL
authors.lastname: Chuang
authors.forename: Kun-Po
authors.initials: KP
authors.lastname: Chen
authors.forename: Winston W
authors.initials: WW
authors.lastname: Shen
mesh_terms: D014150:Antipsychotic Agents / Q000008:administration & dosage / Q000009:adverse effects*; D001569:Benzodiazepines / Q000008:administration & dosage / Q000009:adverse effects*; D001714:Bipolar Disorder / Q000150:complications* / Q000188:drug therapy*; D005260:Female; D006801:Humans; D008133:Long QT Syndrome / Q000139:chemically induced*; D008875:Middle Aged; D000077152:Olanzapine; D014927:Wolff-Parkinson-White Syndrome / Q000150:complications*
chemical_list: D014150:Antipsychotic Agents; D001569:Benzodiazepines; D000077152:Olanzapine